Several brokerages have updated their recommendations and price targets on shares of Establishment Labs (NASDAQ: ESTA) in the last few weeks:
- 8/13/2026 – Establishment Labs was upgraded by Citigroup Inc. from “neutral” to “buy”. They now have a $92.00 price target on the stock.
- 8/7/2026 – Establishment Labs had its price target raised by JPMorgan Chase & Co. from $84.00 to $95.00. They now have an “overweight” rating on the stock.
- 8/6/2026 – Establishment Labs was given a new $105.00 price target by Canaccord Genuity Group Inc..
- 8/6/2026 – Establishment Labs had its price target raised by BTIG Research from $96.00 to $103.00. They now have a “buy” rating on the stock.
- 8/6/2026 – Establishment Labs had its price target raised by Needham & Company LLC from $86.00 to $95.00. They now have a “buy” rating on the stock.
- 8/3/2026 – Establishment Labs had its price target raised by TD Cowen from $95.00 to $117.00. They now have a “buy” rating on the stock.
- 7/15/2026 – Establishment Labs had its price target raised by Mizuho from $100.00 to $105.00. They now have an “outperform” rating on the stock.
- 7/13/2026 – Establishment Labs had its “buy” rating reaffirmed by BTIG Research.
- 7/8/2026 – Establishment Labs had its price target raised by Citigroup Inc. from $76.00 to $92.00. They now have a “neutral” rating on the stock.
- 6/24/2026 – Establishment Labs had its “sell (e+)” rating reaffirmed by Weiss Ratings.
Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.
The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.
See Also
- Five stocks we like better than Establishment Labs
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Establishment Labs Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
